Association of serum cystatin C with white matter abnormalities in patients with amnestic mild cognitive impairment.


Journal

Geriatrics & gerontology international
ISSN: 1447-0594
Titre abrégé: Geriatr Gerontol Int
Pays: Japan
ID NLM: 101135738

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 20 05 2019
revised: 30 07 2019
accepted: 06 08 2019
pubmed: 7 9 2019
medline: 13 3 2020
entrez: 7 9 2019
Statut: ppublish

Résumé

White matter hyperintensities (WMH) on MRI have been reported to be a risk factor for the conversion from mild cognitive impairment (MCI) to Alzheimer's disease, although the reason remains unclear. In the present study, we hence investigated the associations between WMH volumes and cognitive function, blood levels of various molecules, and the presence of lifestyle-associated diseases in patients with amnestic MCI. The initial data of 38 patients with amnestic MCI and 10 normal control individuals were analyzed. The volumes of periventricular hyperintensities (PVH) and deep WMH (DWMH) were measured on T2 fluid-attenuated inversion recovery using the imaging software, 3D Slicer; and the association between PVH/DWMH volumes and cognitive function, blood levels of molecules (such as cystatin C [CysC], 25-hydroxyvitamin D and homocysteine) and the presence of lifestyle-associated diseases (such as hypertension, hyperlipidemia and diabetes mellitus) were analyzed. In the MCI group, the PVH volume : intracranial volume ratio significantly correlated with Trail Making Test-A/B scores and CysC level by Pearson's analysis, and the PVH volume : intracranial volume ratio significantly correlated with only CysC levels, whereas the DWMH volume : intracranial volume ratio did not correlate with any items at all by linear multiple regression analysis. PVH volume was closely associated with frontal lobe dysfunction, particularly with attention and executive dysfunction. Serum CysC level was associated with PVH volume, which suggests that CysC might be a useful marker for determining treatment strategies for white matter abnormalities in amnestic MCI. Geriatr Gerontol Int 2019; 19: 1036-1040.

Identifiants

pubmed: 31489777
doi: 10.1111/ggi.13767
pmc: PMC6852519
doi:

Substances chimiques

Cystatin C 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1036-1040

Subventions

Organisme : JSPS KAKENHI
ID : JP17K09327

Informations de copyright

© 2019 The Authors Geriatrics & Gerontology International published by John Wiley & Sons Australia, Ltd on behalf of Japan Geriatrics Society.

Références

Acta Neuropathol. 2007 Jan;113(1):13-21
pubmed: 17021755
Geriatr Gerontol Int. 2019 Oct;19(10):1036-1040
pubmed: 31489777
Stroke. 2006 Jun;37(6):1391-8
pubmed: 16627790
Neurobiol Aging. 2014 Apr;35(4):769-76
pubmed: 24199958
J Neurol. 2008 Sep;255(9):1302-8
pubmed: 18825439
J Exp Med. 2017 Nov 6;214(11):3151-3169
pubmed: 29061693
J Magn Reson Imaging. 2001 Jun;13(6):967-75
pubmed: 11382961
J Neurol Sci. 2014 Nov 15;346(1-2):288-92
pubmed: 25248955
Hypertension. 2005 Jul;46(1):200-4
pubmed: 15911742
Neuroimage. 2005 Dec;28(4):1014-21
pubmed: 16129627
Neuron. 2008 Oct 23;60(2):247-57
pubmed: 18957217
Biol Psychiatry. 1988 Mar 1;23(5):519-22
pubmed: 3345325
PLoS One. 2017 Sep 14;12(9):e0184999
pubmed: 28910415
Brain. 2012 Dec;135(Pt 12):3749-56
pubmed: 23204143
J Neuropathol Exp Neurol. 2001 Jan;60(1):94-104
pubmed: 11202179
Stroke. 2008 Jan;39(1):55-61
pubmed: 18048865
Stroke. 2007 Nov;38(11):2924-30
pubmed: 17885256
J Cereb Blood Flow Metab. 2019 Jan;39(1):36-43
pubmed: 29106319
Alzheimers Dement. 2011 May;7(3):257-62
pubmed: 21514247
AJR Am J Roentgenol. 1987 Aug;149(2):351-6
pubmed: 3496763
Acta Neurol Scand. 2008 Jul;118(1):60-7
pubmed: 18261165
AJNR Am J Neuroradiol. 2014 Jun;35(6):1145-9
pubmed: 24436348
PLoS One. 2014 Oct 08;9(10):e108333
pubmed: 25295736
J Neurol Sci. 2009 Aug 15;283(1-2):79-82
pubmed: 19268974
J Nucl Med. 1995 Jul;36(7):1238-48
pubmed: 7790950
Eur Neurol J. 2009 Sep;1(1):33-50
pubmed: 22763426
Stroke. 2005 Jan;36(1):50-5
pubmed: 15576652
BMC Neurol. 2017 Oct 6;17(1):192
pubmed: 28985720
Eur J Neurol. 2010 Mar;17(3):383-90
pubmed: 19832902
Am J Kidney Dis. 2000 Jul;36(1):29-34
pubmed: 10873868
Arch Neurol. 2007 Feb;64(2):266-72
pubmed: 17296844

Auteurs

Kentaro Hirao (K)

Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan.

Fumio Yamashita (F)

Department of Ultrahigh Field MRI, Institute for Biomedical Sciences, Iwate Medical University, Iwate, Japan.

Akito Tsugawa (A)

Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan.

Rieko Haime (R)

Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan.

Raita Fukasawa (R)

Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan.

Tomohiko Sato (T)

Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan.

Misa Okita (M)

Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan.

Soichiro Shimizu (S)

Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan.

Hidekazu Kanetaka (H)

Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan.

Takahiko Umahara (T)

Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan.

Hirofumi Sakurai (H)

Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan.

Haruo Hanyu (H)

Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH